BioCentury
ARTICLE | Company News

Axentis, BioDevelops deal

June 30, 2008 7:00 AM UTC

Axentis acquired BioDevelops Pharma for an undisclosed amount. The acquisition gave Axentis exclusive rights to IP covering the use of molecules for the enzymatic removal of ubiquitin markers from inc...